Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with Type 2 diabetes. The Skaraborg Project

Keyphrases

• Type 2 Diabetes Mellitus (T2DM) 100%
• Serum Concentration 100%
• Low Serum 100%
• Sulfatide 100%
• α-galactosylceramide (α-GalCer) 75%
• Odds Ratio 25%
• Diabetes Risk 25%
• Islet 25%
• Confidence Interval 12%
• AIMS™ 12%
• Diabetes 12%
• Insulin 12%
• Type 2 Diabetic Patients 12%
• Fetal Life 12%
• Non-modifiable Risk Factors 12%
• Confounding 12%
• KATP Channel 12%
• B Cells 12%
• Insulin Resistance 12%
• Insulin Secretion 12%
• Population-based Sample 12%
• Phase Response 12%
• Secretory Granules 12%
• Glycolipids 12%
• Glycosphingolipids 12%
• Population Survey 12%
• Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) 12%
• Gender Analysis 12%
• Exocytosis 12%
• Related Compounds 12%
• Neonatal Life 12%

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Sulfatide 100%
• Lactosylceramide 62%
• Diabetes 37%
• Odds Ratio 25%
• Patient with Type 2 Diabetes 12%
• Case-Control Study 12%
• Insulin Release 12%
• Beta Cell 12%
• Insulin Resistance 12%
• Adenosine Triphosphate 12%
• Galactosylceramide 12%
• Glycolipid 12%
• Homeostatic Model Assessment 12%
• Exocytosis 12%
• Glycosphingolipid 12%
• Secretory Granule 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Sulfatide 100%
• Lactosylceramide 55%
• Case-Control Study 11%
• Adenosine Triphosphate 11%
• Insulin Resistance 11%
• Glycosphingolipid 11%
• Glycolipid 11%
• Galactosylceramide 11%